CAR-T Translational Opportunities in Paediatric Cancers

29 April 2021

Event Name: 

ACTRIS Cell Therapy Lecture Series: CAR-T Translational Opportunities in Paediatric Cancers


29 April 2021


12 noon to 1pm


Chimeric Antigen Receptor T-cell (CAR-T) therapy has changed the paradigm for the treatment of relapsed or refractory paediatric cancers for patients who have otherwise exhausted all treatment options.

However, the rapid translational success of cell therapy in B-lineage acute lymphoblastic leukaemia and lymphomas is not met with the same speed of translation in other paediatric cancers.

This talk will present an overview of the current successes and challenges of CAR-T treatment in paediatric cancers, including and beyond B-cell acute lymphoblastic leukaemia, and discuss where the unmet needs are for potential translational effects.


Dr Michaela Seng

Consultant, Paediatric Haemotology and Oncology

KK’s Women’s and Children’s Hospital